Giant SEPs and SEP-recovery function in Unverricht-Lundborg disease

Clinical Neurophysiology

Volumn 124, Issue 5, 2013, Pages 1013-1018

  Visani, E ^a   Canafoglia, L ^a   Rossi Sebastiano, D ^a   Agazzi, P ^a,b   Panzica, F ^a   Scaioli, V ^a   Ciano, C ^a   Franceschetti, S ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b Ospedale Civico Lugano   (Switzerland)

Author keywords

Giant SEPs; Myoclonus; SEP recovery cycle; Unverricht Lundborg disease

Indexed keywords

BENZODIAZEPINE; ETIRACETAM; LAMOTRIGINE; PHENOBARBITAL; PIRACETAM; TOPIRAMATE; VALPROIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE COURSE; EVOKED SOMATOSENSORY RESPONSE; FEMALE; HUMAN; MALE; MYOCLONUS EPILEPSY; NERVE STIMULATION; PRIORITY JOURNAL; SCHOOL CHILD; STIMULUS RESPONSE;

ADOLESCENT; ADULT; AGED; ELECTRIC STIMULATION; EVOKED POTENTIALS, SOMATOSENSORY; FEMALE; HUMANS; MALE; MEDIAN NERVE; MIDDLE AGED; NEURAL INHIBITION; RECOVERY OF FUNCTION; UNVERRICHT-LUNDBORG SYNDROME; YOUNG ADULT;

EID: 84876114320     PISSN: 13882457     EISSN: 18728952     Source Type: Journal    
DOI: 10.1016/j.clinph.2012.11.011     Document Type: Article

References (36)

1. Buzzi A., Chikhladze M., Falcicchia C., Paradiso B., Lanza G., Soukupova M., et al. Loss of cortical GABA terminals in Unverricht-Lundborg disease. Neurobiol Dis 2012, 47:216-224.
2. Canafoglia L., Ciano C., Panzica F., Scapoli V., Zucca C., Agazzi P., et al. Sensorimotor cortex excitability in Unverricht-Lundborg disease and Lafora body disease. Neurology 2004, 63:2309-2315.
3. Canafoglia L., Ciano C., Visani E., Anversa P., Panzica F., Viri M., et al. Short and long interval cortical inhibition in patients with Unverricht-Lundborg and Lafora body disease. Epilepsy Res 2010, 89:232-237.
4. Desmedt J.E., Bourguet M. Color imaging of parietal and frontal somatosensory potential fields evoked by stimulation of median or posterior tibial nerve in man. Electroencephalogr Clin Neurophysiol 1985, 62:1-17.
5. Franceschetti S., Sancini G., Buzzi A., Zucchini S., Paradiso B., Magnaghi G., et al. A pathogenetic hypothesis of Unverricht-Lundborg disease onset and progression. Neurobiol Dis 2007, 25:675-685.
6. Frasson E., Priori A., Bertolasi L., Mauguiere F., Fiaschi A., Tinazzi M. Somatosensory disinhibition in dystonia. Mov Disord 2001, 16:674-682.
7. Genton P. Unverricht-Lundborg disease (PME1). Rev Neurol (Paris) 2006, 162:819-826.
8. Hamada Y., Otsuka S., Okamoto T., Suzuki R. The profile of the recovery cycle in human primary and secondary somatosensory cortex: a magnetoencephalography study. Clin Neurophysiol 2002, 113:1787-1793.
9. Hitomi T., Ikeda A., Matsumoto R., Kinoshita M., Taki J., Usui K., et al. Generators and temporal succession of giant somatosensory evoked potentials in cortical reflex myoclonus: epicortical recording from sensorimotor cortex. Clin Neurophysiol 2006, 117:1481-1486.
10. Höffken O., Lenz M., Tegenthoff M., Schwenkreis P. Multichannel SEP-recording after paired median nerve stimulation suggests origin of paired-pulse inhibition rostral of the brainstem. Neurosci Lett 2010, 468:308-311.
11. Hoshiyama M., Kakigi R. New concept for the recovery function of short-latency somatosensory evoked cortical potentials following median nerve stimulation. Clin Neurophysiol 2002, 113:535-541.
12. Ikeda A., Shibasaki H., Nagamine T., Xu X., Terada K., Mima T., et al. Peri-rolandic and fronto-parietal components of scalp-recorded giant SEPs in cortical myoclonus. Electroencephalogr Clin Neurophysiol 1995, 96:300-309. [Erratum in: Electroencephalogr Clin Neurophysiol 1995;96:484].
13. Kälviäinen R., Khyuppenen J., Koskenkorva P., Eriksson K., Vanninen R., Mervaala E. Clinical picture of EPM1-Unverricht-Lundborg disease. Epilepsia 2008, 49:549-556.
14. Karhu J., Hari R., Paetau R., Kajola M., Mervaala E. Cortical reactivity in progressive myoclonus epilepsy. Electroencephalogr Clin Neurophysiol 1994, 90:93-102.
15. Kobayashi K., Matsumoto R., Kondo T., Kawamata J., Hitomi T., Inouchi M., et al. Decreased cortical excitability in Unverricht-Lundborg disease in the long-term follow-up: a consecutive SEP study. Clin Neurophysiol 2011, 122:1617-1621.
16. Lenz M., Höffken O., Stude P., Lissek S., Schwenkreis P., Reinersmann A., et al. Bilateral somatosensory cortex disinhibition in complex regional pain syndrome type I. Neurology 2011, 77:1096-1101.
17. Machii K., Ugawa Y., Kokubo Y., Sasaki R., Kuzuhara S. Somatosensory evoked potential recovery in Kii amyotrophic lateral sclerosis/parkinsonism-dementia complex (Kii ALS/PDC). Clin Neurophysiol 2003, 114:564-568.
18. Magaudda A., Gelisse P., Genton P. Antimyoclonic effect of levetiracetam in 13 patients with Unverricht-Lundborg disease: clinical observations. Epilepsia 2004, 45:678-681.
19. Manganotti P., Tamburin S., Zanette G., Fiaschi A. Hyperexcitable cortical responses in progressive myoclonic epilepsy: a TMS study. Neurology 2001, 57:1793-1799.
20. Mochizuki H., Hanajima R., Kowa H., Motoyoshi Y., Ashida H., Kamakura K., et al. Somatosensory evoked potential in myotonic dystrophy. Clin Neurophysiol 2001, 112:793-799.
21. Mochizuki H., Machii K., Terao Y., Furubayashi T., Hanajima R., Enomoto H., et al. Recovery function of and effects of hyperventilation on somatosensory evoked high-frequency oscillation in Parkinson's disease and myoclonus epilepsy. Neurosci Res 2003, 46:485-492.
22. Pennacchio L.A., Lehesjoki A.E., Stone N.E., Willour V.L., Virtaneva K., Miao J., et al. Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 1996, 271:1731-1734.
23. Pranzatelli M.R., Tate E., Huang Y., Haas R.H., Bodensteiner J., Ashwal S., et al. Neuropharmacology of progressive myoclonus epilepsy: response to hydroxy-l-tryptophan. Epilepsia 1995, 36:783-791.
24. Prince D.A., Connors B.W. Mechanisms of interictal epileptogenesis. Adv Neurol 1986, 44:275-299.
25. Ragazzoni A., Ferri R., Di Russo F., Del Gracco S., Barcaro U., Navona C. Giant somatosensory evoked potentials in different clinical conditions: scalp topography and dipole source analysis. Electroencephalogr Clin Neurophysiol Suppl 1999, 49:81-89.
26. Shibasaki H., Ikeda A., Nagamine T., Mima T., Terada K., Nishitani N., et al. Cortical reflex negative myoclonus. Brain 1994, 117:477-486.
27. Shibasaki H., Yamashita Y., Neshige R., Tobimatsu S., Fukui R. Pathogenesis of giant somatosensory evoked potentials in progressive myoclonic epilepsy. Brain 1985, 108:225-240.
28. Tamura Y., Matsuhashi M., Lin P., Ou B., Vorbach S., Kakigi R., et al. Impaired intracortical inhibition in the primary somatosensory cortex in focal hand dystonia. Mov Disord 2008, 23:558-565.
29. Torres-Escalante J.L., Barral J.A., Ibarra-Villa M.D., Pérez-Burgos A., Góngora-Alfaro J.L., Pineda J.C. 5-HT1A, 5-HT2, and GABAB receptors interact to modulate neurotransmitter release probability in layer 2/3 somatosensory rat cortex as evaluated by the paired pulse protocol. J Neurosci Res 2004, 78:268-278.
30. Ugawa Y., Genba K., Shimpo T., Mannen T. Somatosensory evoked potential recovery (SEP-RF) in myoclonic patients. Electroencephalogr Clin Neurophysiol 1991, 80:21-25.
31. Ugawa Y., Genba-Shimizu K., Kanazawa I. Somatosensory evoked potential recovery (SEP-R) in various neurological disorders. Electroencephalogr Clin Neurophysiol 1996, 100:62-67.
32. Vaarmann A., Kaasik A., Zharkovsky A. Altered tryptophan metabolism in the brain of cystatin B-deficient mice. A model system for progressive myoclonus epilepsy. Epilepsia 2006, 47:1650-1654.
33. Valeriani M., Restuccia D., Di Lazzaro V., Le Pera D., Tonali P. The pathophysiology of giant SEPs in cortical myoclonus: a scalp topography and dipolar source modelling study. Electroencephalogr Clin Neurophysiol 1997, 104:122-131.
34. Valeriani M., Rinalduzzi S., Vigevano F. Multilevel somatosensory system disinhbition in children with migraine. Pain 2005, 118:137-144.
35. Virtaneva K., D'Amato E., Miao J., Koskiniemi M., Norio R., Avanzini G., et al. Unstable minisatellite expansion causing recessively inherited myoclonus epilepsy, EPM1. Nat Genet 1997, 15:393-396.
36. Vollono C., Ferraro D., Miluicci R., Vigevano F., Valeriani M. The abnormal recovery cycle of somatosensory evoked potential components in children with migraine can be reversed by topiramate. Cephalalgia 2010, 30:17-26.